Intravenous Segment to Register Highest CAGR during 2021–2028
According to our latest study on “Sterile Compounding Pharmacies Market Analysis and Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product and Route of Administration and Geography. The market is estimated to grow from US$ 3,968.70 million in 2021 to US$ 6,198.59 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.
Based on product, the sterile compounding pharmacies market is bifurcated into injectable drugs and infusions. The injectable drugs segment would account for a larger market share during 2021–2028.
By route of administration, the sterile compounding pharmacies market is segmented into intravenous, intramuscular, and subcutaneous. The intravenous segment dominates the market and is projected to continue its dominance during the forecast period.
Drug demand surged during the early months of the COVID-19 pandemic due to scarcity in the supply of pharmaceuticals. To address such scarcity issue, the Alliance for Compounding Pharmacies recommended a bill in Congress that focuses on expanding the situations for which 503As can assist with the shortages. One such example is the implementation of 503As (503A is a traditional compounding pharmacy that compounds in relation to patient-specific prescriptions and complies with USP guidelines) and 503Bs (503B pharmacies are the only compounding pharmacies that are able to provide office-use (or office-administered medications) for justifying compounding practices. For records, 503Bs can mass produce and sell formulations to entities, such as hospitals, without a prescription for a specific patient. Such factors have eliminated shortages occurring in the first place during the pandemic.
Fagron, Inc; Triangle Compounding Pharmacy; B. Braun Melsungen AG; PharMEDium Healthcare Holdings, Inc.; Fresenius Kabi AG; Avella specialty pharmacy; Pencol Compounding Pharmacy; Pavilion Compounding Pharmacy, LLC; Pace Pharmacy; and SandsRx are among the leading companies operating in the sterile compounding pharmacies market.
Sterile Compounding Pharmacies Market, by Region, 2021 (%)
Sterile Compounding Pharmacies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Injectable Drugs and Infusions) and Route of Administration (Intravenous, Intramuscular, and Subcutaneous), and Geography 
Sterile Compounding Pharmacies Market Size & Growth Report 2028
Download Free Sample
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com